Docket Number:13A-950606
Inventor:Hung Li, Woei-Cherng Shyu
IP Status:Issued TWI327473, US 7,618,938B2, EP2139510,WO pending
Abstract:
This invention relates to a method for treating a cerebrovascular disease with erythropoietin (EPO) and granulocyte-colony stimulating factor (G-CSF) jointly by first identifying a subject in need of the treatment and then administering to the subject an effective combined amount of EPO and G-CSF. Also disclosed is a method for increasing in a subject expression of EPO with G-CSF.
Fields of Application:
Treatment for cerebrovascular diseases.
Advantages when compared to the existing technologies:
- New indication
- GCSF and EPO are generic drugs. Licensee can produce and develop the product.
- There is now effective drug for cerebrovascular diseases.
Contact Person:
對本技術有興趣,請於本處網頁廠商選項下(廠商需求與諮詢)網頁填寫資料,承辦人將跟您聯絡。
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Apply for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office, and the undertaker will contact you.
